Intravitreal Ranibizumab for the Prevention of Radiation Maculopathy Following Plaque Radiotherapy
Clinical trial NCT00540930 · UNKNOWN
Trial details
- NCT number
- NCT00540930
- Sponsor
- Shields, Shields and Associates
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2007-04-01
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.